END of PROJECT REPORT Use One Template for All CDC Awards
Total Page:16
File Type:pdf, Size:1020Kb
“BAYLOR COLLEGE OF MEDICINE CHILDREN’S FOUNDATION - UGANDA” END OF PROJECT REPORT Use one template for all CDC Awards managed by the organization Send the completed report to Cooperative Agreement’s Activity Manager, the Monitoring Team Lead on [email protected] and Program Grants Office on email [email protected]. For inquiries/comments, send to [email protected] Partner Name: Baylor College of Medicine Children’s Foundation - Uganda Physical Address: Mulago Hospital Complex Block 5, Kampala Program Title: Strengthening National Pediatric HIV/AIDS and Scaling up comprehensive HIV/AIDS Services in The Republic of Uganda under the President’s Emergency Plan for AIDS Relief (PEPFAR) Cooperative Agreement Number: Reporting period: 1st October 2012 – 31st March 2018 Contact Information: (PI, M&E and Finance) Name: Adeodata Kekitiinwa Name: Albert Maganda Name: Title: Executive Director Email:akekitiinwa@bylor- Title: Director Planning and Title: Director Finance uganda.org M&E Email: Tel No:+256 772-462686 Email:amaganda@baylor- Tel No: Signature: uganda.org Signature: Tel No: +256 772-485174 Signature: Date of submission: Acknowledgement and Disclaimer: “This publication was supported by cooperative agreement number “1U2GGH000848-02” from Centers for Disease Control and Prevention (CDC). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC.” Page 1 of 82 Table of Contents Table A: Partner intervention area summary ........................................................................................ 9 Executive Summary .......................................................................................................................10 Acronyms and definitions ..............................................................................................................12 A. Cooperative Agreement Background .......................................................................................13 B. Program Area Summaries .........................................................................................................15 C. Project Achievements, lessons learned, pending gaps and follow‐up issues ............................18 C.1 Objective 1: Scale up access to comprehensive pediatric and adolescent HIV/AIDS/TB care and treatment at the Baylor Uganda Center of Excellence (COE). .........................................18 C.1.1 HIV testing and early infant diagnosis (EID) program: .......................................................18 C.1.2 Care and Treatment: .............................................................................................................18 C.1.3 TB/HIV Services: .................................................................................................................20 C.1.4 OVC services: ......................................................................................................................20 C.1.5 Medical logistics and commodities: .....................................................................................20 C.1.5 Laboratory services: .............................................................................................................20 C.2 Objective 2: Scale up access to comprehensive HIV care and treatment services in Rwenzori region. ......................................................................................................................................21 C.2.1: Increasing the coverage and utilization of Provider Initiated Testing and Counseling (PITC) services within the health facilities in Rwenzori region ..............................................21 C2.2 HIV testing services (HTS) among children and adolescents ...............................................22 C2.3 Care and Treatment ...............................................................................................................23 C2.4 Peadiatric and Adolescent care & treatment: ........................................................................23 C2.5 Viral load suppression among children and adolescents .......................................................25 C2.6 Trends of patients in care (2012-2018)-TX-CURR ..............................................................25 C2.6 12 months ART Retention.....................................................................................................26 C2.7 Serum CRAG Performance: ..................................................................................................30 C2.8: Increased access to TB/HIV services ...................................................................................31 C2.8.1: TB Case Notification.........................................................................................................31 C2.9 TB Case Notification rate by district, March 2018 ...............................................................32 C2.10 TB Treatment Outcomes .....................................................................................................32 C2.11 Nutritional Support among PLHIV: ....................................................................................33 C2.12 Burden of malnutrition among active ART clients .............................................................35 C3 Expanding coverage and utilization of PMTCT services in target districts .............................36 C3.1 Access to HIV testing services within ANC .........................................................................36 Acknowledgement and Disclaimer: “This publication was supported by cooperative agreement number “insert co-operative agreement numbers” from Centers for Disease Control and Prevention (CDC). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC.” Page 2 of 82 C3.2 PMTCT linkage to care .........................................................................................................36 C3.3 Exposed Infant Diagnosis (EID) services .............................................................................37 C3.4 Reduction in HIV positivity rate among HIV Exposed Infants by 1st PCR (2012 - 2018) ...37 C3.5 PMTCT-EID Final Outcomes ...............................................................................................38 C4 Increased access to and utilization of prevention services to reduce sexual transmission of HIV ..........................................................................................................................................38 C4.1 Access to HTS among Key and Priority Populations ...........................................................38 C4.2 Pre-Exposure Prophylaxis (PrEP) .........................................................................................40 C4.3 GBV/HIV integration ............................................................................................................40 C4.4 Condom promotion and distribution .....................................................................................41 C4.5 Voluntary Medical Male circumcision:.................................................................................42 C5 Scaling up access to comprehensive OVC services to OVCs and their Household ................42 C5.1 OVC Served in Rwenzori region ..........................................................................................42 C5.2 Case management:.................................................................................................................45 C5.3 Health: ...................................................................................................................................45 C6 Community facility framework ................................................................................................45 C6.1 Facility-Community referrals, linkages and service delivery: ..............................................46 C7. Objective 2.1: Scale up access to comprehensive HIV care and treatment services at Fort Portal Regional Referral Hospital. ...........................................................................................47 C7.1 HTS Performance SNAPS-West Project Support to the FPRRH- ........................................47 C7.2 PMTCT: ................................................................................................................................47 C7.3: CARE AND TREATMENT: ...............................................................................................49 C7.4 FPRRH Viral load Monitoring: .............................................................................................49 C7.5 TB/HIV: ................................................................................................................................50 C7.6 TB treatment outcomes: ........................................................................................................51 C8. Objective 3: Support MOH and its partners Strengthen National Pediatric/adolescent HIV/AIDS Care and provide training, mentorship and technical support supervision to RRHs and lower health facilities providing HIV care and ART services over the project period. ....52 C9. Objective 4: Strengthen implementation of district based programming approach and support integration of GHI principles into comprehensive HIV/AIDS care and treatment and other health services over the project period. ....................................................................................54 C9.1 Leadership and governance ...................................................................................................54